Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
Yazar: | Feldinger, K |
---|---|
Diğer Yazarlar: | Kong, A |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2012
|
Konular: |
Benzer Materyaller
Benzer Materyaller
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
Yazar:: Schulz, J
Baskı/Yayın Bilgisi: (2013) -
The role and regulation of Asterless in the centrosome cycle
Yazar:: Novak, ZA
Baskı/Yayın Bilgisi: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
Yazar:: Grijzenhout, A
Baskı/Yayın Bilgisi: (2013) -
Cell stress response and hypoxia in breast cancer
Yazar:: Milani, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
Yazar:: Johnson, J
Baskı/Yayın Bilgisi: (2011)